Umbelliferone inhibits proliferation and metastasis via modulating cadherin/β-catenin complex-aided cell-cell adhesion in glioblastoma cells
Advances in Clinical and Experimental Medicine · 2025
DOI: 10.17219/acem/192547 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical and Experimental Medicine, 2025. Verfasst von Wei Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Second Affiliated Hospital of Air Force Medical University, Xi'an, China. Hauptthemen laut MEDLINE: Glioblastoma, Cell Proliferation, Cell Adhesion, Umbelliferones. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The Second Affiliated Hospital of Air Force Medical University, Xi'an, China.
- Department of Neurosurgery, The Affiliated Children's Hospital of Xi'an Jiaotong University, Xi'an Children's Hospital, China.
Zitieren
APA
Ma, W., Shi, H., Dong, X., Shi, Y., Zhang, L., & Jiang, B. (2025). Umbelliferone inhibits proliferation and metastasis via modulating cadherin/β-catenin complex-aided cell-cell adhesion in glioblastoma cells. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/192547
Vancouver
Ma W, Shi H, Dong X, Shi Y, Zhang L, Jiang B. Umbelliferone inhibits proliferation and metastasis via modulating cadherin/β-catenin complex-aided cell-cell adhesion in glioblastoma cells. Advances in Clinical and Experimental Medicine. 2025. doi:10.17219/acem/192547
BibTeX
@article{Ma2025,
author = {Ma, Wei and Shi, Hangyu and Dong, Xinya and Shi, Yongqiang and Zhang, Luyi and Jiang, Bin},
title = {Umbelliferone inhibits proliferation and metastasis via modulating cadherin/β-catenin complex-aided cell-cell adhesion in glioblastoma cells},
journal = {Advances in Clinical and Experimental Medicine},
year = {2025},
doi = {10.17219/acem/192547}
}
EUVIMED